
P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT
Lindstrom, Beatriz F, Ruckle, Jon L, Turner, Stewart A, Stauber, Kathe, Brierley, Stuart M, English, Brett A, Yacyshyn, BruceVolume:
25
Journal:
Inflammatory Bowel Diseases
DOI:
10.1093/ibd/izy393.154
Date:
February, 2019
Fichier:
PDF, 265 KB
2019